Objective: To review recent findings by DNA microarray in bipolar disorder (BD).
I
n spite of extensive studies, pathophysiology of BD is still enigmatic. The role of genetic factors is well established from twin studies, but the causative genes or genetic risk factors have not been well established. 1 The other well-studied area of biological research is neuroimaging. Those studies suggested that the volume of several brain areas, such as anterior cingulate, amygdala, and hippocampus, are altered in BD. 2 However, the results are not always consistent with each other. The most established finding is that there is increased incidence of subcortical hyperintensity detected by MRI, although such a finding is not specific to BD because this is frequently seen in healthy, elderly people. The third important area of research would be postmortem brain studies. 3 Before the SMRI 4 started its activity to provide brain bank samples to anyone with an adequate research plan, the number of postmortem brain studies of BD patients was quite small. Since SMRI started to provide the samples, the number of studies dramatically increased and the postmortem brain study became a hot research area. Another area of study involved obtaining peripheral blood samples. One replicated finding obtained from such studies is altered basal or agoniststimulated calcium levels in blood cells derived from patients with BD. 5 In addition to those studies involving patients' samples, studies focusing on the pharmacology of mood stabilizers are also widely performed. To date, a number of hypotheses to account for the action mechanisms of mood stabilizers have been suggested and are still controversial.
In this situation, the recent development of comprehensive gene expression analysis using DNA microarray is expected to be a powerful tool to identify molecular pathophysiology of BD (see Figure 1 ). Since Bezchlibnyk et al 6 first used DNA microarray for the study of BD, this technology has been applied to postmortem brains, peripheral leukocytes, transformed lymphoblastoid cells, and biopsied olfactory neuroepithelium derived from patients with BD.
In this review, studies focusing on molecular cascades related to pathophysiologic mechanisms of BD are summarized (see Table 1 ). After the postmortem brain studies are summarized by subcategorizing the findings into several sections, studies of peripheral blood cells and neuroepitherium are introduced. Finally, limitations and future directions are presented. Detailed methodological issues regarding the platforms used for the DNA microarray analysis and the method of data analysis were discussed elsewhere.
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Postmortem Brain Studies
Initial Studies
Sun and colleagues 8 used the serial analysis of gene expression method to identify the differentially expressed genes in the postmortem brains of a patient with BD in comparison with an age-and sex-matched control subject. They found upregulation of serotonin transporter and NF-kB2 genes and confirmed these findings in a case-control study in the brains of 19 patients with BD and 15 controls. The upregulation of serotonin transporter mRNA in BD may be compatible with a recent finding showing increase of serotonin transporter binding potential in vivo measured by positron emission tomography. 9 A recent study showed increased levels of NF-kB protein in lymphocytes obtained from 15 patients with bipolar depression, compared with 25 controls, 10 which may be in accordance with the initial finding in postmortem brains.
Bezchlibnyk et al 6 used a cDNA microarray carrying about 1200 genes to search for genes relevant to biochemical process of BD. They mixed the RNA extracted from postmortem brain samples obtained from 10 patients with BD or 10 controls obtained from Stanley Foundation Neuropathology Consortium and analyzed by a set of cDNA microarray. They reported differential expression of 24 genes, and focused on 5 candidate genes. They validated the finding of decreased TGF-1b1 by analyzing individual samples by RT-PCR method. The results showed statistically significant decrease of TGF-1b1 expression. TGF-1b1 is a multifunctional cytokine involved in various functions such as cell growth and differentiation, and thus a possible role in BD was suggested. Reduced TGF-1â1 level was also reported in plasma of 70 patients with mania, compared with 96 controls. 11 It was rather higher in patients with schizophrenia, 12 and higher 15 Genetic association analysis showed association with BD, while the association with schizophrenia is not consistent in 2 studies. 16, 17 More recently, reduced expression of PDLIM5 was found to be related to depressive state. 18 These combined findings suggest the role of PDLIM5 expression may be a biomarker for mental disorders.
Chaperones and Stress Response Genes
Jurata et al 19 also performed comprehensive gene expression analysis in the postmortem brains of patients with BD and controls. They used 2 platforms, oligonucleotide microarray (Affymetrix Hu133A) and cDNA microarray (Agilent Human 1), to compare the efficiency of these platforms to detect differentially expressed genes. First, they used parietal cortex samples of 1 bipolar patient and 1 control. They subsequently examined 8 prefrontal cortex samples each of patients with BD and controls. They concluded that sensitivity to detect the differential expression was higher in oligonucleotide array than in cDNA microarray. They reported 47 genes showing differential expression using both platforms. There was no overlap with the findings by Bezchlibnyk et al. 6 However, upregulation of genes of chaperones or stress response proteins, such as GRP94 (gp96) and interferon-induced transmembrane protein 2, is similar to the finding by Iwamoto et al, 14 who reported upregulation of several chaperone or stress response genes such as HSPF1 and interferon induced transmembrane protein 3. Upregulation of HSPF1 was also found in lymphoblastoid cell lines in patients with both bipolar I 14 and bipolar II disorders. 15 Increased expression of endoplasmic reticulum chaperons such as GRP78, GRP94, and calreticulin is also reported in patients with major depression who died by suicide. 
Mitochondria-Related Genes
Konradi et al 21 performed gene expression analysis in the hippocampal samples of 9 patients with BD and 10 controls, as well as 8 patients with schizophrenia, obtained from Harvard Brain Bank, using oligonucleotide microarray. They found that mitochondria-related genes were globally downregulated in BD. They found that genes related to mitochondrial oxidative phosphorylation or ubiquitin proteasome pathway. They discussed that the effect of drugs cannot explain this finding because patients with schizophrenia taking similar drugs did not show such marked global downregulation of mitochondria-related genes. They interpreted that this finding reflects mitochondrial dysfunction in BD.
Global downregulation of mitochondria-related genes had also been observed in postmortem brains samples with low pH or agonal factors such as prolonged hypoxia and ischemia. 22, 23 Indeed, sample pH was significantly lower in BD group in the study of Konradi et al. 21 Thus the finding in BD may be explained by those factors. Iwamoto et al 24 disease and confounding factors to observe the gene expression patterns in postmortem brains. Whereas they classified the genes affected by disease and (or) agonal-pH factors, they were prudent enough to avoid proposing any particular genes as specific to BD. They also found that copy number of mtDNA tended to be increased in the patients with BD. Sun et al 2 6 replicated the finding of global downregulation of mitochondria-related genes and effects of pH, but proposed that reduced pH itself might be a reflection of mitochondrial dysfunction in BD.
Munakata et al 27 reanalyzed the previously reported DNA microarray data focusing on mitochondrial genes. They found that LARS2 was upregulated in BD. Because a well characterized mitochondrial DNA 3243 A>G mutation on mitochondrial leucyl tRNA is reported to impair the amioacylation of tRNA catalyzed by LARS2, they hypothesized that this finding might be compensatory upregulation by the presence of the mtDNA 3243 mutation. They verified that LARS2 was indeed upregulated in the cybrids carrying 3243G mutation and, using the protein nucleic acid-clamped PCR method, they searched for this mutation in the postmortem brains. They found that 3 patients, 2 with BD and 1 with schizophrenia, showed relatively high level of 3243 mutation, not only in the brain but also in the liver. This suggested that accumulation of mtDNA mutation in the brain might play a part in the pathophysiology of BD.
While many mitochondria-related genes were reported to be downregulated, possibly reflecting low sample pH, increased expression of NDUFV2 encoding 24kDa subunit of complex I in parietotemporal or frontal cortices was reported by 2 groups. 28, 29 This is compatible with upregulation of NDUFV2
in the rat depression model of learned helplessness. 30 On the other hand, reduced NDUFV2 level was found in lymphoblastoid cells of BD patients. 31 Reduced NDUFV2 level was correlated with downregulation of other mitochondria-related genes in lymphoblastoid cells. 32 Although this was initially attributed to promoter polymorphisms, 31,33 the genetic association was not replicated in extended samples.
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Ubiquitin Pathway
Ryan et al 34 examined the prefrontal and orbitofrontal cortices samples from the Stanley Microarray Collection and performed comprehensive gene expression analysis. No significant alteration was found in the prefrontal cortex, while ubiquitin pathway is dowregulated and G-protein coupled receptors were upregulated in orbitofrontal cortex.
GABA Neuron Markers
In the data by Konradi et al, 21 downregulation of GAD67 and SST, both of which are markers of GABAergic neurons, was also reported. Downregulation of SST and GAD67 was replicated in our analysis (Iwamoto et al, unpublished finding). Somatostatin concentrations in cerebrospinal fluid in patients with BD showed conflicting results: decrease, 35 no change, 36 or increase. 37 These findings may be in accordance with reduced GAD67 positive GABAergic neurons in BD 38, 39 or decreased GABA concentration measured by in vivo proton magnetic resonance spectroscopy. 40 Conversely, Nakatani et al 29 used the samples from an Australian brain bank to perform gene expression analysis and found the differential expression of 8 genes (RAP1GA1, SST, HLA-DRA, KATNB1, PURA, NDUFV2, STAR, and PAFAH1B3), including the upregulation of SST. Although the observed change of SST was in the opposite direction to previous studies, their subsequent genetic association study showed the association between SNP markers of SST and BD.
GABA and Glutamate Receptors
Choudary et al 41 reported that 2 GABA receptor genes (GABRA5 and GABBR1) were upregulated in the dorsolateral prefrontal cortex. Dysfunction of subpopulation of GABAergic interneurons and compensatory upregulation of GABAergic receptors on pyramidal neurons has been suggested as a pathophysiological mechanism of schizophrenia. 42 These observations may reflect the pathophysiology shared by these 2 mental disorders.
Three GR genes (GRIA1, GRIA3, and GRM3) were also shown to be upregulated in the dorsolateral prefrontal cortex and (or) anterior cingulate cortex. On the other hand, downregulation of GRIK1 encoding kainate type GR found in this study is in accordance with other reports. 54 These findings suggest that downregulation of GABAergic interneuron-related genes, mitochondria-related genes, and oligodendrocyte-related genes may be common to schizophrenia and BD, although there are some inconsistencies. However, it is also possible that these apparent alterations might reflect the effects of confounding factors such as agonal-pH factors, medication, and cause of death.
When all confounding factors are controlled, the number of samples and the power of analysis decreases. Thus it is a matter of debate about how these factors should be controlled. 7
Public Database
As described above, SMRI played a significant role in the postmortem brain studies of BD. After this brain bank started to distribute the brain samples to researchers, the number of papers on postmortem brain studies in BD markedly increased. Although intellectual property rights belonged to the SMRI when these brain bank samples were used, these data were not used for commercial purpose but were made open to the public. 55 This database will further facilitate the research of BD. However, the list of differentially expressed genes in the database tend to be different from the original report, reflecting the different methods for data analysis, exclusion of confounding factors, and so on. This might potentially cause confusion among the researchers who are not familiar with the DNA microarray studies using postmortem brains.
Summary of Findings
As written above, altered expression of chaperone and stress response genes, mitochondria-related genes, GABAergic neuron markers such as SST and GAD1, GRIK1 encoding kinate type GR, and oligodendrocyte-related genes were replicated in more than one study. Several expression changes detected in postmortem brains, such as NF-kB, TGF-1â1, PDLIM5, HSPF1, and NDUFV2, were also detected in peripheral blood cells and thus might be used as biomarkers for BD.
Peripheral Blood Cells and Olfactory Neuroepithelium
Monozygotic Twins Discordant for BD
Kakiuchi et al 56 used oligonucleotide microarray for the analysis of lymphoblastoid cell lines derived from 2 pairs of monozygotic twins discordant for BD and 1 pair of control twins. Among the genes commonly downregulated in these 2 pairs of twins, XBP1 and HSPA5 (GRP78) were related to ER stress response, and they further focused on this pathway. ER stress response was attenuated in the lymphoblastoid cells derived from patients with BD in a small case-control study. They identified a SNP, !116 C/G, which impairs XBP1-induced XBP1 expression, owing to loss of XBP1 binding site on its promoter. This SNP was associated with BD in the original report, but subsequent studies did not support this association. 57, 58 More recently, So and colleagues 59 also reported that XBP1 induction by ER stress was attenuated in the lymphoblastoid cells derived from patients with BD, but this was not solely explained by XBP1 polymorphism. By searching for the target genes of XBP1 in neuroblastoma cells using DNA microarray, Kakiuchi et al 60 found that WFS1, the causative gene for Wolfram syndrome, is induced by XBP1 through ER stress response element on its promoter. Wolfram syndrome is known to comorbid with mood disorders. This finding supports the role of XBP1-WFS1 pathway in BD.
Search of Peripheral Blood for Biomarkers
Tsuang et al 61 analyzed the gene expression patterns in peripheral blood leukocytes derived from patients with BD and reported that APOBEC3B, ADSS, ATM, CLC, CTBP1, DATF1, CXCL1, and S100A9 would become biomarkers to distinguish the patients from those with schizophrenia or controls. Middleton et al 62 also performed gene expression analysis of peripheral blood leukocytes. By comparing the patients with their healthy sib pairs, upregulation of myc-associated factor X was found. For other 248 genes altered in BD, they discussed the significance of the finding in relation to the genetic linkage loci, and suggested that chromosome 6q showed both linkage and gene expression alteration signals.
Olfactory Neuroepithelium
Considering the difficulties in managing confounding factors in the study of postmortem brain studies, use of olfactory neuroepithelium would be a promising alternative, in spite of its invasiveness. McCurdy et al 63 performed gene expression analysis in biopsied olfactory epithelium derived from patients with BD. They found that cultures from BD patients showed high ratio of cell death, and alteration of apoptosis-related genes were detected by their original oligonucleotide microarray. Genes associated with intracellular inositol signalling were also altered.
Summary of Findings
In summary, endoplasmic reticulum stress pathway was implicated in the pathophysiology of BD based on the findings of discordant twins. Several genes found by gene expression analysis of peripheral blood cells were proposed as biomarkers of BD. A study in olfactory neuroepithelium showed enhanced apoptotic pathway in BD.
Discussion
As described above, data of gene expression analysis in postmortem brains cannot be free from artifacts, owing to premortem or antemortem changes. Such changes may be linked with diagnosis, because the cause of death is different, and pathophysiology of the illness itself may affect these processes. In addition, effect of drugs always confounds the results. Due to these difficulties, the findings obtained by the gene expression analysis using postmortem brains are not conclusive on their own.
Conversely, the analysis of peripheral blood cells also has problems because it is not the target organ of mental disorder and many important genes expressed in the brain are not expressed in peripheral blood cells. Thus only abnormalities of basic metabolism could be assessed in peripheral blood cells. In addition, effects of drugs are difficult to exclude in clinical settings. It is also difficult to distinguish the effect of trait-dependent alteration from state-dependent alteration. Use of lymphoblastoid cell lines would be one way to control these problems.
Use of olfactory neuroepithelium biopsy samples may be a promising alternative. However, because of its invasiveness, such research has been done in only limited institutions.
The only way to obtain conclusive results would be to verify the findings obtained in postmortem brains by multiple approaches, such as analysis of peripheral blood, genetics, animal models, and so on. When the data obtained from these different approaches are compared, methodological consideration is essential because each research strategy has characteristic artifacts, which should be carefully controlled.
In spite of the methodological problems, several findings, such as alterations in GRs, PDLIM5, mitochondrial dysfunction, impaired endoplasmic reticulum stress response, and alterations in GABAergic neurons, are validated by several different strategies. Before concluding that these pathways are important for the pathophysiology of BD, we should verify that these findings are caused by disease process rather than effects of confounding factors using animal models. To clarify the causal relation, behavioural consequence of animal models having abnormalities in these pathways should be examined. If the roles of these cascades are confirmed by those studies, these findings should be tested as peripheral biomarkers. Further studies would clarify the etiology of BD and provide clinically useful biomarkers.
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Résumé : Une analyse exhaustive de l'expression génétique dans le trouble bipolaire Objectif : Examiner les résultats récents d'un jeu ordonné de microéchantillons d'ADN dans le trouble bipolaire (TB).
Méthode : Une recherche de la documentation a été exécutée.
Résultats : Une analyse exhaustive de l'expression génétique dans le cerveau, des globules de sang périphérique, et du neuroépithéliome olfactif serait une stratégie prometteuse pour la recherche sur le TB. Jusqu'ici, les modifications des récepteurs de glutamate (RG), des gènes liés aux mitochondries, des gènes chaperons, des gènes oligodendrocytes, et des marqueurs des neurones d'acide gamma-aminobutyrique (GABAergiques) dans les cerveaux postmortem sont reproduites par plusieurs stratégies différentes. Cependant, les modifications des gènes liés aux mitochondries sont associées avec des facteurs agonaux, un échantillon de pH, et les effets des médicaments. L'analyse des globules sanguins a montré une modification de la voie de stress du réticulum endoplasmique et d'autres cascades moléculaires. L'analyse de l'épithéliome olfactif a montré une expression modifiée des gènes associés à l'apoptose.
Conclusions :
Ces résultats garantissent que l'analyse exhaustive de l'expression génétique par jeu ordonné de microéchantillons d'ADN sera utile pour identifier les cascades moléculaires responsables du TB.
